FDA inspection found violations at Abbott infant formula plant months before recall

LPETTET/iStock Unreleased via Getty Images

• About five months prior to a February recall of Abbott's (NYSE:ABT) Similac powdered infant formula manufactured at a Michigan plant, an FDA inspection of that facility led to the issuance of five violations,